In a clinical study investigating genetic variants in the progression of NAFLD, the PNPLA3 and TM6SF2 mutations were shown to be significantly correlated with increased liver steatosis and fibrosis, confirming their role in disease progression. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.